Morbidity and Mortality Weekly Report (MMWR)

Monkeypox Reports

September 30, 2022

Monkeypox Case Investigation — Cook County Jail, Chicago, Illinois, July–August 2022
Incidence of Monkeypox Among Unvaccinated Persons Compared with Persons Receiving ≥1 JYNNEOS Vaccine Dose — 32 U.S. Jurisdictions, July 31–September 3, 2022

More>

This figure is an infographic with text that says “People eligible for monkeypox vaccination should get vaccinated as soon as possible”. The infographic features data from a study of males ages 18-49 years eligible for vaccination showing 14 male icons to indicate 14 infections per 100,000 people in males who received no doses and 1 male icon to indicate 1 infection per 100,000 people in males who received one dose.

Current Weekly

October 7, 2022

Notes from the Field: E-cigarette Use Among Middle and High School Students — United States, 2022

Also in this issue

Respiratory Virus Surveillance Among Children with Acute Respiratory Illnesses, New Vaccine Surveillance Network — United States, 2016–2021
Preliminary Incidence and Trends of Infections Caused by Pathogens Transmitted Commonly Through Food — Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2016–2021

More>

Surveillance Summaries

October 7, 2022
Surveillance for Sickle Cell Disease — Sickle Cell Data Collection Program, Two States, 2004–2018
In 2015, CDC established the Sickle Cell Data Collection program to characterize the epidemiology of sickle cell disease in California and Georgia. Findings from surveillance can be used to improve and monitor care and outcomes for persons with sickle cell disease.

More>

The figure is a photo of a smiling family on the right half of the image white text on a blue background on the left half that reads, “Monitoring sickle cell disease helps states: know how many people have it; understand the lifetime course of the disease; identify healthcare needs and gaps.”

The figure is a graphic with text that reads, “Recommend the cholera vaccine for your patients based on their travel plans and age.” There are three boxes that explain why, where, and to whom the vaccine should be recommended. It says, “Up to 10% of cholera infections are severe, resulting in diarrhea that can cause severe dehydration and rapid death. Travelers should receive the cholera vaccine before traveling to places with active cholera transmission. The cholera vaccine is recommended for travelers ages 2–64 years old.”

Recommendations and Reports

September 30, 2022
Cholera Vaccine: Recommendations of the Advisory Committee on Immunization Practices, 2022
A CDC report that summarizes recommendations CDC’s Advisory Committee on Immunization Practices for the use of lyophilized CVD 103-HgR vaccine in the United States. Cholera is a toxin-mediated bacterial gastrointestinal illness caused by Vibrio cholerae serogroup O1.

More>

Supplements

April 1, 2022
Adolescent Behaviors and Experiences Survey – United States, January-June 2021
This report summarizes information from nine federal data systems with indicators of children’s mental health during 2013–2019.

Reports by Select Topics

MMWR Visual Abstracts